- Home
- GROY vs CDXS Comparison
GROY vs CDXS Comparison
Compare GROY & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- CDXS
- Stock Information
- Founded
- GROY 2020
- CDXS 2002
- Country
- GROY Canada
- CDXS United States
- Employees
- GROY N/A
- CDXS N/A
- Industry
- GROY
- CDXS Major Chemicals
- Sector
- GROY
- CDXS Industrials
- Exchange
- GROY Nasdaq
- CDXS Nasdaq
- Market Cap
- GROY 206.6M
- CDXS 230.3M
- IPO Year
- GROY 2021
- CDXS 2010
- Fundamental
- Price
- GROY $1.43
- CDXS $2.49
- Analyst Decision
- GROY Strong Buy
- CDXS Buy
- Analyst Count
- GROY 4
- CDXS 2
- Target Price
- GROY $3.31
- CDXS $11.00
- AVG Volume (30 Days)
- GROY 1.4M
- CDXS 1.1M
- Earning Date
- GROY 03-20-2025
- CDXS 05-01-2025
- Dividend Yield
- GROY N/A
- CDXS N/A
- EPS Growth
- GROY N/A
- CDXS N/A
- EPS
- GROY N/A
- CDXS N/A
- Revenue
- GROY $10,103,000.00
- CDXS $59,345,000.00
- Revenue This Year
- GROY $145.05
- CDXS $14.56
- Revenue Next Year
- GROY $48.73
- CDXS $21.41
- P/E Ratio
- GROY N/A
- CDXS N/A
- Revenue Growth
- GROY 231.46
- CDXS N/A
- 52 Week Low
- GROY $1.16
- CDXS $2.43
- 52 Week High
- GROY $2.21
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- GROY 50.11
- CDXS 41.09
- Support Level
- GROY $1.39
- CDXS $2.43
- Resistance Level
- GROY $1.51
- CDXS $3.04
- Average True Range (ATR)
- GROY 0.07
- CDXS 0.22
- MACD
- GROY -0.01
- CDXS 0.07
- Stochastic Oscillator
- GROY 45.31
- CDXS 43.24
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and streaming company. It offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.